发明名称 Oligome-containing pyrrolidine compounds
摘要 The invention relates to (among other things) oligomer-containing pyrrolidine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
申请公布号 US8785661(B2) 申请公布日期 2014.07.22
申请号 US201013319924 申请日期 2010.05.13
申请人 Nektar Therapeutics 发明人 Riggs-Sauthier Jennifer
分类号 C07D207/27 主分类号 C07D207/27
代理机构 代理人 Wilson Mark A.
主权项 1. A compound comprising a pyrrolidine residue covalently attached via a stable linkage to a water-soluble, non-peptidic oligomer, wherein the compound is encompassed within the formula:wherein: each L is independently selected from the group consisting of hydrogen, hydroxyl, a C1-6 alkyl radical, a C2-6 alkenyl radical, and a C2-6 alkynyl radical; p is a whole number from 1 to 6; Y is selected from the group consisting of hydrogen, a C1-6 alkyl radical, a C2-6 alkenyl radical, and a C2-6 alkynyl radical; R2 is selected from the group consisting of hydrogen, an alkyl radical, an alkenyl radical, an alkynyl radical, a cycloalkyl radical, and an aryl radical; X is a spacer moiety; and POLY is a water-soluble, non-peptidic oligomer having a molecular weight of below about 1500 Daltons.
地址 San Francisco CA US